Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

TARO-TEMOZOLOMIDE, Capsules (Cytotoxic)
« Back to list view

Product Information

  • DIN:
    02443473
  • Active Ingredients :
    Temozolomide
  • Innovator Name:
    Temodal®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    5 mg
  • Route of Administration:
    Oral
  • Colour:
    white opaque cap and body, imprinted in green ink.
  • Shape:
    Capsule
  • Markings:
    cap is imprinted with '890'. The body is imprinted with '5 mg' and two stripes.
  • Package size:
    5 blister
  • UPC Code:
    063691077393
  • Description :
    Hard gelatin capsules, with white opaque cap and body, imprinted in green ink. The cap is imprinted with '890'. The body is imprinted with '5 mg' and two stripes. Hard gelatin capsules, Size '4' filled with white to light tan light pink powder.
  • Non-medicinal ingredients :
    Lactose anhydrous, Sodium starch glycolate, Stearic acid and Tartaric acid; capsule shells contain gelatin, sodium lauryl sulfate and titanium dioxide. 5mg capsule shells are imprinted with green printing ink consisting of shellac, propylene glycol, strong ammonia solution, yellow iron oxide, FD&C blue #1 aluminium lake-E133.
TARO-TEMOZOLOMIDE, Capsules (Cytotoxic)

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02443481
  • Active Ingredients :
    Temozolomide
  • Innovator Name:
    Temodal®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    20 mg
  • Route of Administration:
    Oral
  • Colour:
    white opaque cap and body, imprinted in yellow ink.
  • Shape:
    Capsule
  • Markings:
    cap is imprinted with '891'. The body is imprinted with '20 mg' and two stripes.
  • Package size:
    5 blister
  • UPC Code:
    063691077423
  • Description :
    Hard gelatin capsule, with white opaque cap and body, imprinted in yellow ink. The cap is imprinted with '891'. The body is imprinted with '20 mg' and two stripes. Hard gelatin capsules, Size '4' filled with white to light tan / light pink powder.
  • Non-medicinal ingredients :
    Lactose anhydrous, Sodium starch glycolate, Stearic acid and Tartaric acid; capsule shells contain gelatin, sodium lauryl sulfate and titanium dioxide. 20mg capsule shells are imprinted with yellow printing ink consisting of shellac, propylene glycol, strong ammonia solution, yellow iron oxide.
TARO-TEMOZOLOMIDE, Capsules (Cytotoxic)

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02443511
  • Active Ingredients :
    Temozolomide
  • Innovator Name:
    Temodal®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    100 mg
  • Route of Administration:
    Oral
  • Colour:
    white opaque cap and body, imprinted in pink ink.
  • Shape:
    Capsule
  • Markings:
    cap is imprinted with '892'. The body is imprinted with '100 mg' and two stripes.
  • Package size:
    5 blister
  • UPC Code:
    06369077454
  • Description :
    Hard gelatin capsules, with white opaque cap and body, imprinted in pink ink. The cap is imprinted with '892'. The body is imprinted with '100 mg' and two stripes. Hard gelatin capsules, Size '3' filled with white to light tan / light pink powder.
  • Non-medicinal ingredients :
    Lactose anhydrous, Sodium starch glycolate, Stearic acid and Tartaric acid; capsule shells contain gelatin, sodium lauryl sulfate and titanium dioxide. 100mg capsule shells are imprinted with pink printing ink consisting of shellac, propylene glycol, strong ammonia solution, purified water, potassium hydroxide, red iron oxide-E172, yellow iron oxide-E172, FD&C blue #1 aluminium lake-E133, titanium dioxide-E171.
TARO-TEMOZOLOMIDE, Capsules (Cytotoxic)

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02443538
  • Active Ingredients :
    Temozolomide
  • Innovator Name:
    Temodal®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    140 mg
  • Route of Administration:
    Oral
  • Colour:
    white opaque cap and body, imprinted in blue ink.
  • Shape:
    Capsule
  • Markings:
    cap is imprinted with '929'. The body is imprinted with '140 mg' and two stripes.
  • Package size:
    5 blister
  • UPC Code:
    63691077485
  • Description :
    Hard gelatin capsules, with white opaque cap and body, imprinted in blue ink. The cap is imprinted with '929'. The body is imprinted with '140 mg' and two stripes. Hard gelatin capsules, Size '2' filled with white to light tan / light pink powder.
  • Non-medicinal ingredients :
    Lactose anhydrous, Sodium starch glycolate, Stearic acid and Tartaric acid; capsule shells contain gelatin, sodium lauryl sulfate and titanium dioxide. 140mg capsule shells are imprinted with blue printing ink consisting of shellac, propylene glycol, strong ammonia solution, titanium dioxide-E171, FD&C blue #1 aluminium lake-E133.
TARO-TEMOZOLOMIDE, Capsules (Cytotoxic)

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02443554
  • Active Ingredients :
    Temozolomide
  • Innovator Name:
    Temodal®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    250 mg
  • Route of Administration:
    Oral
  • Colour:
    white opaque cap and body, imprinted in black ink.
  • Shape:
    Capsule
  • Markings:
    cap is imprinted with '893'. The body is imprinted with '250 mg' and two stripes.
  • Package size:
    5 blister
  • UPC Code:
    063691077546
  • Description :
    Hard gelatin capsules, with white opaque cap and body, imprinted in black ink. The cap is imprinted with '893'. The body is imprinted with '250 mg' and two stripes. Hard gelatin capsules, Size '0' filled with white to light tan / light pink powder.
  • Non-medicinal ingredients :
    Lactose anhydrous, Sodium starch glycolate, Stearic acid and Tartaric acid; capsule shells contain gelatin, sodium lauryl sulfate and titanium dioxide. 250mg capsule shells are imprinted with black printing ink consisting of shellac, propylene glycol, strong ammonia solution, black iron oxide-E172, potassium hydroxide, purified water.
TARO-TEMOZOLOMIDE, Capsules (Cytotoxic)

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement